Skip to content

Current Psychopharmacology

ISSN 2211-5560

3 papers in the library · 9 citations · publishing 2019-2021

Papers

Sort Most recent Most cited

Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling.

Current Psychopharmacology February 15, 2021 Kenneth Blum, Thomas Mclaughlin, Edward J Modestino et al. 9 citations

During Lucid Dreams, the dreamer is aware, experiences the dream as if fully awake, and may control the dream content. The dreamer can start, stop, and restart dreaming, depending on the nature and pleasantness of the dream. For patients with Reward Deficiency Syndrome (RDS) behaviors, like Attention Deficit Hyperactivity Disorder (ADHD), Tourette's- Syndrome, and Posttraumatic Stress Disorder...

Hallucinogen Use in College Students: Current Trends and Consequences of Use

Current Psychopharmacology August 30, 2020 Lena S. Jia, Jessica A. Gold

Hallucinogens are a drug class that is growing in popularity with college students. Recent experimental trends, such as microdosing, have helped promote the use of hallucinogens on campus, and students may be tempted to use these substances due to their beliefs about the drugs’ positive effects on mood. Although hallucinogens are not currently an established form of medical therapy, studies...

An Insight on the Association of Psychological Studies, Cognitive Sciences and Meditation in Treating Depression

Current Psychopharmacology December 13, 2019 Rashmi S. Pal, Nikita Saraswat, Pranay Wal et al.

Background: Depression is the neuropsychiatric disorder that can lead to the disruption of brain nerves by elevating different mechanisms and neurotransmitters such as serotonin, noradrenaline, dopamine. It can have a series of episodic events that can cross one episodic depression to another and manifest various symptoms such as agitation, melancholia, deep sadness, psychomotor retardation,...